Holen Sie sich die Stockscreener-App
6.11
2.52%
0.15
Handel nachbörslich:
6.11
Schlusskurs vom Vortag:
$5.96
Offen:
$5.96
24-Stunden-Volumen:
108.28K
Relative Volume:
0.93
Marktkapitalisierung:
$347.95M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-66.86M
KGV:
-5.0917
EPS:
-1.2
Netto-Cashflow:
$-58.82M
1W Leistung:
+8.33%
1M Leistung:
+54.29%
6M Leistung:
+21.23%
1J Leistung:
+27.03%
1-Tages-Spanne:
$5.61
$6.14
1-Wochen-Bereich:
$5.24
$6.14
52-Wochen-Spanne:
$2.60
$7.77
Design Therapeutics Inc Stock (DSGN) Company Profile
Firmenname
Design Therapeutics Inc
Sektor
Branche
Telefon
858-293-4900
Adresse
6005 HIDDEN VALLEY ROAD, CARLSBAD
Vergleichen Sie DSGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DSGN
Design Therapeutics Inc
|
6.11 | 326.31M | 0 | -66.86M | -58.82M | -1.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Design Therapeutics Inc Stock (DSGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-05-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-11-14 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-08-15 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-08-15 | Herabstufung | SVB Securities | Outperform → Market Perform |
| 2023-08-15 | Herabstufung | Wedbush | Outperform → Neutral |
| 2023-05-04 | Hochstufung | Goldman | Sell → Neutral |
| 2022-06-10 | Eingeleitet | Wedbush | Outperform |
| 2022-05-02 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-01-19 | Eingeleitet | Goldman | Sell |
| 2021-04-20 | Eingeleitet | Goldman | Neutral |
| 2021-04-20 | Eingeleitet | Piper Sandler | Overweight |
| 2021-04-20 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Design Therapeutics Inc Aktie (DSGN) Neueste Nachrichten
Is Design Therapeutics Inc. a good stock for dollar cost averagingJuly 2025 Market Mood & Low Risk Profit Maximizing Plans - khodrobank.com
Published on: 2025-09-03 12:30:21 - Newser
Applying big data sentiment scoring on Design Therapeutics Inc.Bull Run & Consistent Return Strategy Ideas - Newser
Combining machine learning predictions for Design Therapeutics Inc.M&A Rumor & Technical Pattern Based Signals - Newser
Understanding Design Therapeutics Inc.’s price movementWeekly Profit Report & Safe Entry Point Identification - Newser
Historical volatility pattern of Design Therapeutics Inc. visualized2025 Volatility Report & Precise Swing Trade Entry Alerts - Newser
Tools to assess Design Therapeutics Inc.’s risk profileMarket Trend Report & Fast Momentum Stock Entry Tips - Newser
Pattern recognition hints at Design Therapeutics Inc. upside2025 Trading Recap & Verified Swing Trading Watchlists - Newser
Can swing trading help recover from Design Therapeutics Inc. lossesIndex Update & High Conviction Buy Zone Alerts - Newser
Is Design Therapeutics Inc. stock reversal real or fakeJuly 2025 Institutional & High Win Rate Trade Tips - Newser
Has Design Therapeutics Inc. formed a bullish divergenceTrade Entry Report & Smart Money Movement Tracker - Newser
Using data models to predict Design Therapeutics Inc. stock movementWeekly Risk Summary & Real-Time Chart Pattern Alerts - Newser
Can a trend reversal in Design Therapeutics Inc. lead to recoveryPortfolio Gains Report & Safe Swing Trade Setups - Newser
Can Design Therapeutics Inc. deliver alphaJuly 2025 Setups & Free Low Drawdown Momentum Trade Ideas - khodrobank.com
Design Therapeutics, Inc. shares rise 3.98% intraday after Twist Bioscience collaboration for novel antibody-drug conjugates. - AInvest
Published on: 2025-09-02 20:32:38 - khodrobank.com
Wellington Management Group LLP Purchases Shares of 141,519 Design Therapeutics, Inc. $DSGN - Defense World
Can Design Therapeutics Inc. expand its profit marginsEntry Point & Reliable Volume Spike Alerts - khodrobank.com
Is it too late to sell Janux Therapeutics Inc.Treasury Yields & Community Verified Trade Alerts - Newser
Is Design Therapeutics Inc. currently under institutional pressureMarket Growth Summary & High Conviction Buy Zone Picks - khodrobank.com
Visual trend scoring systems applied to Design Therapeutics Inc.Forecast Cut & Stock Market Timing Techniques - Newser
Will breakout in Design Therapeutics Inc. lead to full recoveryJuly 2025 Rallies & AI Powered Market Entry Strategies - Newser
Long term hold vs stop loss in Design Therapeutics Inc.2025 Earnings Impact & Short-Term High Return Ideas - Newser
What momentum shifts mean for Design Therapeutics Inc.Weekly Trend Summary & Verified Momentum Stock Ideas - Newser
Advanced analytics toolkit walkthrough for Design Therapeutics Inc.Weekly Stock Report & High Accuracy Trade Alerts - Newser
Will Design Therapeutics Inc. stock recover after recent drop2025 Historical Comparison & Precise Swing Trade Entry Alerts - Newser
How to build a custom watchlist for Design Therapeutics Inc.Weekly Market Outlook & Smart Investment Allocation Tips - Newser
Why Design Therapeutics Inc. is moving todayJuly 2025 Market Mood & High Accuracy Trade Signal Alerts - Newser
Will a bounce in Design Therapeutics Inc. offer an exit2025 Year in Review & Daily Profit Maximizing Tips - Newser
Steven Cohen Takes Bold Biotech Bets With Invivyd and Design Therapeutics - AInvest
Steven Cohen's Biotech Bets Are Getting Bolder — And Smaller - inkl
Finanzdaten der Design Therapeutics Inc-Aktie (DSGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):